Here, we revealed a crucial role of HIF-1α in directing angiogenic capacity of transplanted human vascular cells, thereby modulating the immune microenvironment in vivo, further demonstrating a potential causality between ischemia and inflammation, and supporting a potential therapeutic countermeasure against human ischemic diseases. Here, HIF1A is linked to ischemic disease.